Phase II single-arm trial of TKM Ebola Guinea in patients with Ebola virus infections in Sierra Leone.
Active, no longer recruiting
Phase of Trial: Phase II
Latest Information Update: 19 Jun 2015
At a glance
- Drugs TKM-Ebola-Guinea (Primary)
- Indications Ebola virus infections
- Focus Therapeutic Use
- Acronyms RAPIDE
- 19 Jun 2015 According to Tekmira Pharmaceuticals media release, data analysis is ongoing and the full results will be made available as soon as possible.
- 19 Jun 2015 Status changed from recruiting to active, no longer recruiting; as reported in Tekmira Pharmaceuticals media release.
- 13 Mar 2015 New trial record